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Abstract SWISSspine is a so-called pragmatic trial for
assessment of safety and efficiency of total disc arthro-
plasty (TDA). It follows the new health technology
assessment (HTA) principle of ‘‘coverage with evidence
development’’. It is the first mandatory HTA registry of its
kind in the history of Swiss orthopaedic surgery. Its goal is
the generation of evidence for a decision by the Swiss
federal office of health about reimbursement of the con-
cerned technologies and treatments by the basic health
insurance of Switzerland. During the time between March
2005 and 2008, 427 interventions with implantation of 497
lumbar total disc arthroplasties have been documented.
Data was collected in a prospective, observational multi-
center mode. The preliminary timeframe for the registry
was 3 years and has already been extended. Data collection
happens pre- and perioperatively, at the 3 months and 1-
year follow-up and annually thereafter. Surgery, implant
and follow-up case report forms are administered by spinal
surgeons. Comorbidity questionnaires, NASS and EQ-5D
forms are completed by the patients. Significant and clin-
ically relevant reduction of low back pain VAS (70.3–29.4
points preop to 1-year postop, p \ 0.0001) leg pain VAS
(55.5–19.1 points preop to 1-year postop, p \ 0.001),
improvement of quality of life (EQ-5D, 0.32–0.73 points
preop to 1-year postop, p \ 0.001) and reduction of pain
killer consumption was revealed at the 1-year follow-up.
There were 14 (3.9%) complications and 7 (2.0%) revisions
within the same hospitalization reported for monoseg-
mental TDA; there were 6 (8.6%) complications and 8
(11.4%) revisions for bisegmental surgery. There were 35
patients (9.8%) with complications during followup in
monosegmental and 9 (12.9%) in bisegmental surgery and
11 (3.1%) revisions with new hospitalization in monoseg-
mental and 1 (1.4%) in bisegmental surgery. Regression
analysis suggested a preoperative VAS ‘‘threshold value’’
of about 44 points for increased likelihood of a minimum
clinically relevant back pain improvement. In a short-term
perspective, lumbar TDA appears as a relatively safe and
efficient procedure concerning pain reduction and
improvement of quality of life. Nevertheless, no prediction
about the long-term goals of TDA can be made yet. The
SWISSspine registry proofs to be an excellent tool for
collection of observational data in a nationwide framework
whereby advantages and deficits of its design must be
considered. It can act as a model for similar projects in
other health-care domains.
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Introduction
For the greatest part, spinal surgery deals with problems of
degenerative spinal diseases with pain and/or radiculopa-
thy. When pharmacological and functional treatment
strategies fail, surgical interventions remain as ultima ratio
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in many cases. The fusion of affected lumbar segments in
surgical candidates with chronic low back pain has been
the standard surgical procedure for almost 50 years and
remains the gold standard until today [6]. There are,
however, well-known problems with the technique [7].
Total disc arthroplasty (TDA) is, for what we know
today, a promising complement to fusion, although,
choosing the right patient for the right procedure probably is
the key to success. The goals of TDA must nowadays cer-
tainly be listed as pain reduction over time, functional
improvement, durability of the implant, safety at the time of
implantation, safety during the life time of the implant, and
safety in case of revision. The protection from adjacent
segment disease (ASD) seems to be a more theoretical and
biomechanical concept since recent clinical and radio-
graphic long-term studies in patients after spinal fusion
conclude that ASD is more likely to be determined by
individual factors than by the fusion itself [12]. Interest-
ingly, whilst mid-term results are promising, long-term
results over 10 years are less favourable [13]. Therefore,
TDA is one of the most controversially discussed motion
preserving concepts of today. Various types of prosthesis
are currently available but rising costs and their containment
are increasingly important issues in all modern health-care
systems. Orthopaedic surgery is a discipline under special
focus. Many orthopaedic interventions are expensive and do
not directly save lives. Nevertheless, in cases like, e.g. joint
arthroplasty their impact on patients’ quality of life,
regained mobility and independence are undisputed. Spinal
surgery is the fastest growing orthopaedic subspecialty.
Scientific evidence, however, is lacking for many inter-
ventions and innovations in this sector. Short-term results
are supported by studies with a high level of evidence. Mid-
and long-term evidence, however, is still poorly available
[1]. Randomized controlled trials for new implants and
indications and rigorous long-term post-market surveillance
for adverse events is called for [5]. The Swiss Federal Office
of Health decided to conduct a nationwide observational
study according to the principle of ‘‘coverage with evidence
development’’ before taking the final decision about reim-
bursement of TDA by the basic health insurance [11].
This article reports the methodology and implementa-
tion of the SWISSspine registry and the early results of the
cases with lumbar TDA. The analysis is based on the
specifications that the Swiss Federal Office of Public
Health (SFOPH) demanded for the health technology
assessment (HTA) reports of the registry.
Materials and methods
Initiated in March 2005, the SWISSspine registry is
ongoing until today. The preliminary timeframe for the
registry was 3 years and has meanwhile been extended for
at least another year. Given the new restrictions for market
release of medical innovations in Switzerland, the implant
industry had approached the decision-making political
bodies and the Swiss Society for Spinal Surgery (SGS)
with the aim to form a task force for implementing a
medical device registry for collecting data and providing
the evidence of the safety and what Archie Cochrane
described as ‘‘efficiency’’ of TDA, i.e. its performance in
the clinical setting [3]. In other parts of the world this term
is sometimes also referred to as ‘‘efficacy’’. The Institute
for Evaluative Research in Orthopedic Surgery at the
University of Bern (IEFO), an international leader in the
field of registry implementation was mandated to serve as
technology provider and organizer of the SWISSspine
registry. In a working group consisting of stakeholders of
industry, the Swiss Spine Society (SGS) and the IEFO, the
different tasks and duties were assigned. An expert com-
mittee of the society generated the basic hypotheses and
worked up the medical content accordingly. Industry
partners provided funding according to market share and
support for device-related questions, and the IEFO con-
sulted and finally implemented all questionnaires in an
online and paper-based version for optical mark reader
scanning on its scientific documentation portal
www.memdoc.org. Hereby, all content needed to be
available in three of the four official Swiss languages:
German, French, and Italian. While each participant can
make use of its own data, the data pool is owned by the
SGS that can delegate data analysis to individual surgeons
or to a neutral academic data clearing centre like the IEFO.
A unique manoeuvre in the Swiss medical profession
policy making was the formation of an SGS expert group
that decided about certification of spine surgeons. In order
to obtain it, a formal application with proof of qualification
and infrastructure had to be submitted by all Swiss spine
surgeons who intended to perform TDA. Along with the
approval went the written consent to participate in the
registry. The certification can be withdrawn if data analysis
shows an unacceptably high number of complications or if
the proportion of documented interventions is too low. For
the latter, the industry partners deliver their sales figures to
the SGS registry group and the IEFO delivers the numbers
of documented interventions.
Content and follow-up schemes
Documentation forms and outcome instruments that are
used to achieve the documentation standards for the
SWISSspine registry are listed as follows:
• Primary intervention forms for TDA (surgeon
administered)
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• Implant form (for TDA barcode stickers)
• Follow-up form for TDA (surgeon administered)
• Euroqol-5D (patient assessment)
• NASS (patient assessment)
• Comorbidity questionnaire (patient assessment)
• Two patient consent forms (one remains at the treat-
ment centre, one at IEFO)
• One annotation form about the registry and its purpose
(also signed by patient)
At the time of surgery, primary intervention and implant
forms are completed by the surgeon. Informed written
consent about participation in the registry has to be given
by the patient as well as a completed set of EQ-5D, NASS
and comorbidity questionnaire. During follow-ups, sched-
uled at 3 months, 1 year and annually thereafter, follow-up
questionnaires are completed by the surgeon. Patients are
again asked to complete the EQ-5D and NASS question-
naires. Validated translations of all patient-based
instruments needed to be available for all the three lan-
guages. With one exception only, all surgeons outsourced
data entry to the technical staff at IEFO. Paper question-
naires are sent to the institute by mail where data is
punched or questionnaires are scanned. Surgeons can
autonomously view, print or analyze their data via the
online interface after the data has been entered into the
MEMdoc database.
Statistical analysis
Wilcoxon rank-sum test was used for comparisons between
baseline and follow-up examinations of continuous vari-
ables such as pain VAS. When comparing proportions, the
v2 test was used.
In 2003, Ha¨gg et al. [10] reported the minimum clini-
cally relevant improvement in low back pain to be 18–19
points on VAS. Based on this finding, we defined the
desired outcomes for the 1-year follow-up as:
• achievement of back pain relief C18 points on VAS
• achievement of leg pain relief C18 points on VAS
For the EQ-5D an improvement C0.25 points was
arbitrarily set as desired outcome.
Multiple logistic regression models were built in order
to identify possible covariates with a significant influence
on the three outcomes.
Prosthesis model, patient sex, patient age, preoperative
pain levels, preoperative EQ-5D score, surgical volume of
centre of intervention, number of levels of intervention, the
level of intervention and pharmacologically treated
depression were included as covariates in the initial
models.
For the surgical volume, clinics were categorized into
four classes: \10 operations, 10–20 operations, 21–30
operations, and [30 operations, respectively. The patient
age was categorized into four age groups according to the
quartiles of the underlying age distribution: 18.5–
37.0 years, 37.1–41.8 years, 41.9–47.2 years and 47.3–
64.7 years, respectively. Using backward elimination of
covariates with a p [ 0.05, a list of significant variables was
received. For the analysis of courses of pain alleviation,
quality of life improvement and for calculation of threshold
values linear regression models were built. The necessary
preconditions of linear relationship between the two
respective variables, constant error variance around the
regression line and normally distributed data were suffi-
ciently given. This level of significance was used throughout
the complete study. The stability of the multiple logistic
regression models was assessed using Hosmer and Leme-
show Goodness-of-Fit test. All statistical analyses were
conducted using SAS 9.1 (SAS Institute Inc, Cary, NC).
Sample characteristics
In March 2008, 36 months after registry launch, there were
427 patients with 497 lumbar TDAs recorded in the data-
base, which corresponds with an about 80% documentation
rate when compared with the sales figures. There were 241
females (56.4%) and 186 males (43.6%). Mean ages were
41 years (range 18.5–64.7 years) and 43.4 years (range
19.6–64 years), respectively, at the time of surgery. 19.6%
of operations were bisegmental. Distribution of comor-
bidities revealed that about 13.4% of patients had a
depression and 10.5% regularly took medication for it
(Fig. 1). In total, 896 lumbar TDA follow-up records from
11 to 915 days (about 2.5 years) postoperative were com-
pleted and stored in the database. Also 1,253 (360
preoperative, 893 follow-up) EQ-5D forms and 1,242
NASS (365 preop, 877 followup) forms for evaluation of
general and disease-specific quality of life were available
for evaluation. For the regression analysis, we used the last
available followup in postoperative year one; that way 365
records with a mean follow-up time of 6 months could be
analyzed. Also, 342 comorbidity questionnaires were
assessed. Between 30 and 40 patients had no followup
information recorded on either the NASS and/or EQ-5D
and/or surgeon-based follow-up forms. These patients were
not any different to the patients with follow-up information
with respect to their demographics, preoperative pain levels
or quality of life. However, 17.1% of patients without
followups had indicated a pharmacologically managed
depression before surgery compared with 10.4% in the
patient group with followups.
Eur Spine J (2009) 18:851–861 853
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Results
Pain relief
Low back pain
One of the main advantages of lumbar TDA is the fast and
efficacious pain reduction. Measurement of pain was con-
ducted with VAS scores on the patient administered NASS
questionnaire.
The mean preoperative back pain was 70.3 points. At the
3 months follow-up (88.2% follow-up rate), it was reduced
to a mean of 30.5 points and to 29.4 points 1-year post-
operative (69% followup rate) (p \ 0.001 for both follow-
up intervals) (Fig. 2). An exploratory analysis of the
available 2-year follow-ups in 83 patients revealed a mean
back pain score of 27.1 points. However, some patients had
worsening of back pain or did not achieve a minimum
clinically relevant back pain alleviation (Fig. 3).
Leg pain
The mean preoperative leg pain was 55.5 points. A
reduction to 23.3 points after 3 months followed by a
decrease to 19.9 points at the 1-year postoperative follow-
up (p \ 0.001 for both followup intervals) was observed
(Fig. 4). The same follow-up rates as for back pain apply.
An exploratory analysis of the available 2-year follow-ups
in 83 patients revealed a mean leg pain score of 17.4 points.
As with back pain, some patients had worsening of leg pain
or did not achieve a minimum clinically relevant leg pain
alleviation (Fig. 5).
Reduction of pain medication
The consumption of pain killers decreased significantly.
The amount of patients who did not need any pain
medication increased from 2.5% preoperative to 65.6%
at the 3 months follow-up and to 61.8% at 1 year
Fig. 1 Preoperative
comorbidities of the study
sample
Fig. 2 Course of pre- to
postoperative back pain
alleviation over the first
postoperative year. The linear
regression shows the average
pain over the postoperative
time. The dotted lines are 95%
confidence intervals
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postoperative (p \ 0.001 for both follow-up intervals).
The proportion of patients consuming NSAIDs decreased
from 69.6% before the intervention to 28.8% at 3 months
postoperative and 29.4% at the 1-year follow-up
(p \ 0.001 for both follow-up intervals). Morphine and
morphine derivates were needed by 28% of patients
before surgery. This number was reduced to 5.6% at the
3 months follow-up and showed a slight increase to 8.8%
at 12 months postoperative (p \ 0.001 for both follow-up
intervals).
Quality of life improvement
Improved quality of life was achieved by significant pain
reduction and consequently decreased pain killer con-
sumption. Values of the EQ-5D range from 1 (best possible
QoL) to -0.6 (QoL worse than death). On preoperative
examination, the mean EQ-5D score was 0.32 points. It
improved to 0.72 points at 3 months (88.5% follow-up rate)
and to 0.73 points at the 1-year follow-up (72.3% follow-up
rate) (p \ 0.0001 for both intervals). 27.1% of patients
Fig. 3 Distribution of patients with back pain improvement/worsening
Fig. 4 Course of pre- to
postoperative leg pain
alleviation over the first
postoperative year. The linear
regression shows the average
pain over the postoperative
time. The dotted lines are 95%
confidence intervals
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indicated a preoperative QoL below zero. This percentage
was reduced to 6.4% at the 1-year follow-up (p \ 0.0001).
An exploratory analysis of the available 2-year follow-ups
in 83 patients revealed a mean EQ-5D score of 0.81 points.
Factors influencing pain relief and QoL improvement
Assessing factors with a possible significant influence on
pain alleviation or quality of life improvement in the first
year after surgery, we included the above described
covariates into the regression models.
Of all analyzed covariates, preoperative back pain
(p \ 0.001) and leg pain (p = 0.048) had an influence on
the postoperative back pain relief. The higher the preop-
erative back pain values were, the higher was the chance
for a clinically relevant back pain alleviation; the lower the
preoperative pain levels the lower was the chance for a
relative pain improvement. The odds ratio for preoperative
back pain was 1.53 (95% CI 1.3–1.79) per additional 10
points on VAS. This means that each increase of preop-
erative back pain by 10 points implies an increase of the
chance for a clinically relevant back pain alleviation by
53%. The opposite influence was seen with preoperative
leg pain. The odds ratio was 0.89 (95% CI 0.78–0.99),
which means that a decrease of preoperative leg pain by 10
points implies an increase of the chance for a clinically
relevant back pain alleviation by 12%. The stability of the
model was confirmed by the Hosmer and Lemeshow
Goodness-of-Fit test (p [ 0.05).
Preoperative leg pain (p \ 0.001) had an influence on
the postoperative leg pain relief. The odds ratio for pre-
operative leg pain was 3.54 (95% CI 2.23–5.62) per 10
points on VAS. This means that an increase of preoperative
leg pain by 10 points implies a 3.5 times higher chance for
a clinically relevant leg pain alleviation. The model was
also stable (p [ 0.05).
The preoperative EQ-5D score (p \ 0.001) and a phar-
macologically treated depression (p = 0.042) had a
significant influence on the postoperative quality of life
improvement. The odds ratio for the preoperative EQ-5D
score was 0.95 (95% CI 0.94–0.96) per 0.1 point preop-
erative score increase. This means that a decrease of the
preoperative EQ-5D score by 0.1 points implies an increase
of the chance for a clinically relevant score improvement
by 5%. The odds ratio for pharmacologically treated
depression was 3.3 (95% CI 1.14–9.33). Hence, the
patients without depression had a 3.3 times higher chance
for a clinically relevant EQ-5D score improvement. The
stability of the model was confirmed (p [ 0.05). A sensi-
tivity analysis with an EQ-5D score improvement of either
0.15 points or of 0.35 points as desired outcome did not
reveal other significant covariates.
Stratifying patients with a pharmacologically treated
depression and those without, the following differences in
pre- and postoperative QoL were revealed: non-depressed
patients had a mean preop Qol of 0.34 points versus 0.12
points in the depressed group. At 3 months postop, these
differences were 0.73 (nd) versus 0.53 (depr) and at 1-year
postop they were 0.77 (nd) versus 0.6 (depr) (Fig. 6).
There was no difference in pain relief between the dif-
ferent prostheses models, the various treatment centres, the
levels of intervention or in single level versus bisegmental
interventions in the registry. Also, patient age or sex did
not influence pain relief or QoL improvement.
Fig. 5 Distribution of patients with leg pain improvement/worsening
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We examined the allocation of patients in terms of the
minimum clinically relevant back pain improvement of 18
points versus preoperative back pain and performed a lin-
ear regression analysis. Evaluating the interception for the
MCRPI with the regression-graph, a ‘‘threshold-value’’ of
43.8 points for preoperative back pain was revealed
(Fig. 7). Analyzing the percentage of patients below the
preoperative pain threshold, 10.1% were below the back
pain threshold; 14.3% were above the back pain threshold
but did not achieve the MCRPI.
Complications and revisions
Complications were assessed by the surgeons themselves
and marked as vascular lesion, ureteral lesion, vertebral
body fracture, sintering of prosthesis into vertebral body and
dura lesion, as predefined on the surgery questionnaire, or
marked as ‘‘other complication’’ with written specification.
On the follow-up forms, they were described as (new)
complications—none, implant related, access/surgery rela-
ted. Specification of complications: perfusion problems after
Fig. 6 Differences in pre- to
postoperative QoL in non-
depressed and depressed
patients. The linear regression
shows the average scores for
both samples over the
postoperative time. The dotted
lines are 95% confidence
intervals
Fig. 7 Threshold values for
clinically relevant back pain
relief of 18 points on VAS
Eur Spine J (2009) 18:851–861 857
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vessel injury, sympathectomy effect, new radiculopathy
level 1, new radiculopathy level 2, retrograde ejaculation,
other. Specification of perfusion problems: disappeared
since … (date), still present but improved, still present but
unchanged. Same for sympathectomy effect, retrograde
ejaculation, radiculopathy level 1, radiculopathy level 2.
Intraoperative complications/revisions
Analyzing 357 monolevel interventions, intraoperative
complications occurred 14 times (3.9%) during one level
surgery. Seven revisions (2%) within the same hospital stay
were recorded.
The 70 bisegmental lumbar interventions revealed six
intraoperative complications (8.6%) and eight revisions
(11.4%) within the same hospital stay (Table 1).
Complications/revisions during FU
There were 44 patients with 47 recorded complications
during followup: 35 patients (9.8%) after a monosegmental
operation and 9 patients (12.9%) with 12 complications
after bisegmental surgery (Table 2).
Additionally, there were 11 revisions with a second hos-
pitalization for monolevel surgeries (3.1%) as well as one
revision for a bilevel surgery (1.4%). The indications for
monosegmental revisions were: one implant removal, three
ventral spondylodesis, two cases of lumbar pain, one dorsal
spondylodesis, one spondylodesis without specification, one
decompression, one wound revision, and one vertebral body
endplate fracture. The indication for the revision of the single
patient with bilevel operation stayed unspecified; however,
DIAM stabilization of the lower adjacent level was performed.
Length of stay
The mean length of stay for patients with a monosegmental
cervical intervention was 7.8 days; that of patients with
bisegmental TDA was one half day longer, i.e. 8.3 days.
Table 1 Intraoperative complications and revisions during hospital
stay
Intraoperative
complications
Monosegmental
TDA (N = 357)
Bisegmental
TDA (N = 70)
Blood vessel injury 10 3
Ureter injury 1 –
Vertebral body fracture 1 1
Sintering of implant 1 1
Dura lesion 1 1
Total 14 (3.9%) 6 (8.6%)
Revisions during hospitalization 7 (2%) 8 (11.4%)
Table 2 Complications
recorded during followup
Type of complication Overall frequency
(percentage)
Monosegmental
TDA (N = 357)
Bisegmental
TDA (N = 70)
Delayed wound healing/wound infection 3 3 –
Incision hernia/abdominal hernia 2 2 –
Cutaneal nerve irritation 1 1 –
Abdominal pain 2 1 1
Testicular pain 1 1 –
Recurring pain 2 2 –
Sympathectomy effects 8 6 2
Retrograde ejaculation 2 1 1
Urethral problem 1 1 –
Radiculopathy 7 6 1
Drop foot 2 – 2
Psychogenic foot paralysis 1 1 –
OA facet joint 1 – 1
Residual disc sequester 1 1 –
Fx endplate 2 2 –
Dislocation 3 1 2
Spondylolisthesis 1 1 –
Foot pain intermittent 1 – 1
Functional foot paralysis 1 1 –
Unspecified 5 4 1
Total 47 (11%) 35 (9.8%) 12 (17%)
Revision after discharge 12 (2.8%) 11 (3.1%) 1 (1.4%)
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Discussion
Since its implementation in the year 2005, the SWISSspine
registry can meanwhile be considered a successful endeav-
our. It is the first nationwide project of its kind. The
collaboration of all participants—surgeons, the Swiss Spinal
Society, the Institute for Evaluative Research in Orthopedic
Surgery and the implant suppliers—helped making the
creation of a national HTA registry under the mandate of the
Swiss Federal Office of Public Health a positive experience.
A relatively high number of observational datasets could be
acquired in a short period of time. The main intentions of this
study, proof of safety and efficiency of TDA, were fulfilled
from the short-term outcome perspective and a foundation
for long-term data collection and evaluation was built.
Significant reduction of back and leg pain at the 1-year
follow-up were shown which increased the quality of life
after TDA to a great extent. Applying the observations of
the Swedish lumbar spine study group about a minimum
necessary VAS improvement of 18 points for a clinically
relevant outcome we could show that patients should not
have a preoperative back pain ‘‘threshold value’’ below
approximately 40 points. For the treatment of back and/or
leg pain, TDA seems an efficient and relatively safe option
so far. Since its initiation few major complications and a
small number of revisions were recorded in the SWISS-
spine database. In view of the difficulty and the dangers
inherent to anterior revision, in particular at the L4/L5
level, future results must yet be expected.
The search for predictors of a good outcome revealed
four covariates with a significant influence on pain allevi-
ation and quality of life improvement. Preoperative back
and leg pain as well as the EQ-5D score correlated with their
own postoperative outcome. A pharmacologically treated
depression showed a negative influence on postoperative
quality of life improvement. Analyzing other covariates
such as the number of treated levels, surgical volume of the
participating centres, types of prostheses or patient sex and
age had no influence on postoperative outcome.
With an observational study like the SWISSspine reg-
istry, an evidence level of no more than three can be
reached. The lack of a control group is one of the most
compromising factors, but the increased documentation
burden for an established and routinely reimbursed com-
parator procedure like, e.g. an anterior stand-alone fusion,
was considered unacceptable on a nationwide level.
Therefore, our findings cannot be considered as conclusive
results but must be interpreted on the background of the
problems that are inherent in this prospective multicenter
case-series. Although good results were shown so far, it is
not possible to predict the mid and long-term outcomes of
TDA. A 1-year follow-up period is very short for the
treatment of a vertebral segment with a mechanical implant
that may suffer from wear, corrosion or loosening, while
the segment itself may become ankylosed, undergo late
infection or further degradation of the considered level
(facet joints) or the adjacent levels. Of course, reoccurrence
of pain for unknown reasons may also happen after some
time. No conclusion on none of these aspects can be drawn
after such a short follow-up.
When the registry was initiated, surgeons not only had to
cope with their surgical learning curve and the task of re-
organising established workflows, also an extensive
documentation had to be integrated into the day-to-day
routines. The necessary changes to the content of the doc-
umentation forms during the first year may be an additional
reason for an only slowly improving discrepancy between
sales and documentation figures. Due to this fact, the quality
of the recorded information has probably been affected,
especially during year one of the registry life cycle. The
relatively low number of documented complications and
revisions could be a possible consequence. Undoubtedly,
the lack of a pilot phase must be seen as a major deficit
during project initiation. Time concerns from the point of
view of the industry partners should not be a legitimation
for leaving out a testing and pre-evaluation phase. A pilot
also serves as a learning programme for training all par-
ticipants before the actual registry start. During a pilot,
study content and data collection instruments can be tested
under routine conditions in the various clinical settings.
On the other hand, a possible advantage with a register
like this is the potential for external validity. All Swiss
surgeons performing TDA and therefore patients from all
over Switzerland were involved in the current investiga-
tion. Thus, there is a low probability for selection bias in
the results. Further, the collaboration between implant
industry and documentation centre for comparing sales
versus documentation figures for each individual partici-
pant is a sophisticated and cost-effective monitoring
mechanism for a nationwide observational study. The fig-
ures were compared by a neutral legislative clearing office
and only communicated to the SGS steering group for
issues of confidentiality and competition laws. Countries
that aim at adopting such a study design need to consider
and respect the essential value of a strong collaboration
between all stakeholders for guaranteeing a similar amount
of transparency. In the case of SWISSspine a fully opera-
tional registry had to be accomplished in a minimum
amount of time, now showing the merit of all involved. An
expert institution in study set-up and implementation
together with a readily available technical infrastructure are
necessary to turn such a venture into a success.
The significant and clinically relevant pain relief we
revealed is also reported by other authors investigating the
success of lumbar TDA [2, 14]. We have not found com-
parable analyses about preoperative threshold values for
Eur Spine J (2009) 18:851–861 859
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minimum clinical relevant pain alleviation in the literature.
After the regression analysis had excluded other influential
factors on pain alleviation but the preoperative pain levels
itself, we aimed at investigating the relationship between
the preoperative pain levels and the relative postoperative
improvement. The use of the minimum necessary 18-point
improvement for a clinically relevant result, as suggested
by Ha¨gg et al. [10], revealed a threshold value of about 40
points on the VAS. This result can not be interpreted as a
golden rule or exclusion criterion for future treatments but
it may serve as rule of thumb for assessing the likelihood of
clinical relevant pain alleviation for TDA patients. The
thresholds could be considered as a minimum requirement
and the further patients are above the preoperative VAS of
40 points, the more likely is a clinically relevant pain
alleviation. The regression showed that of all evaluated
factors preoperative back pain and preoperative leg pain
had an influence on back pain relief, and preoperative leg
pain had an influence on leg pain relief; furthermore, the
preoperative EQ-5D score and pharmacologically treated
depression had an influence on postoperative general
quality of life. Other factors not assessed in the SWISS-
spine registry may have an influence as well. The potential
impact of depressive diseases on chronic low back pain and
the insufficient investigation of such comorbidities by
many orthopaedic surgeons is described by some authors
[4, 8]. Correlations of these factors with the treatment
outcome have to be further investigated, but surgeons
should have an increased awareness for their impact on the
treatment results. Contradicting our findings, results from
the Swedish lumbar spine study group showed that a
depressive disorder did not have a negative influence on
outcome after lumbar fusion surgery for chronic low back
pain [9]. The authors did, however, state that these results
might be based on a rather successful selection of patients
since the prevalence of major depression was lower than in
other patient samples. Hence, the negative influence we
found in the current analysis may disappear in future
assessments of SWISSspine data since surgeons may
become more critical and careful in selecting candidates for
lumbar TDA.
Published rates for complications range from 6 to 39%
[4] and the complication rates in SWISSspine are relatively
low. A possible explanation is the framework of SWISS-
spine where only surgeons with a proven expertise in spinal
surgery received certification for the intervention. In
addition, there may have been a benefit from advancements
in instrumentation and access as well as surgical techniques
that the first movers of the technology did not have yet.
Finally, it is possible that the surgeon-based reporting of
complications underrepresents the complication rates from
the patients’ point of view. In the Swedish ‘‘SweSpine’’
registry as well as in the European Spine Tango registry the
patient questionnaires ask some predefined questions about
postoperative use of antibiotics, return to hospital or new
spine surgeries indicating eventual complications from the
index operation. Moreover, patients can indicate in written
any other event that they considered a complication. Such a
form of complication reporting may lead to higher com-
plication rates than the current ones but also improve the
external validity of results. Therefore, future revision and
complication rates need to be awaited.
As opposed to cervical disc prostheses, mid and long-
term outcomes of the lumbar implants have been under
observation for many more years. Nevertheless long-term
outcomes are still rarely reported [13]. The few available
investigations are rather critical in their conclusions as
opposed to the reported more promising mid and short-term
results [4]. Further investigations are undoubtly needed.
The results and knowledge obtained by the SWISSspine
registry show that a nationwide registry with a relatively
large documentation burden can be implemented in a short
period of time and conducted if the consequences of action
are of sufficient importance for all stakeholders. Surgeons
and industry joined forces in order to produce evidence for
the safety, and especially for the efficiency of the inter-
vention and patients agreed to read and complete consent
forms and patient questionnaires in order to receive TDA.
An essential ingredient against wearing-out participants
and loosing the generated momentum and data collection
activities is a feed back loop to the user community. Data
evaluation is not only performed and communicated by the
MEM-Research-Center as organizing central institution but
due to the good accessibility of the MEMdoc-database
every participating clinical department is able to monitor
their individual progress and status quo and to compare
themselves against the pool of participating centres with
online statistical tools. Finally, the Swiss Federal Office of
Public Health has an evidence based background for
defining the framework for future TDA reimbursement.
The set-up and organization of the SWISSspine registry
has introduced a new attitude amongst its participants. The
need for constant documentation and commitment to the
‘‘rules’’ of the registry brakes previous long rehearsed
manners. Transparency and information exchange is
required and will be of increasing importance in future
considerations, also in other medical subspecialties. For
some colleagues this may be a ‘‘cultural clash’’. However,
the potential quality of the generated evidence makes such
new approaches worth being considered. These results may
not only verify or falsify previously made findings of other
investigators but can also generate new information about
the field of investigation like the so far unreported pain
thresholds. Especially in those cases were a surgical
alternative like lumbar fusion exists, the findings, though
not considerable as guidelines, may serve as decision-
860 Eur Spine J (2009) 18:851–861
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making aid for a careful and conservative use of the new
technologies.
As previously mentioned, there are a number of ques-
tions which can not be answered with the SWISSspine
registry, others do only evolve from its results. To continue
the established registry and further evaluate its data pool is
the challenge of the future. Other study designs may be
needed. A logical and scientifically desirable development
could be the creation and integration of a second study arm
receiving fusion. With such a study design, a matched
prospective cohort study would become realizable and
higher quality evidence for or against lumbar TDA gen-
erated. Implementation of randomized control trials
leading to the gold standard of scientific results is not
feasible, nor payable in a national set-up. Moreover, the
SPORT trial has shown that there may be such a high rate
of cross-over to the other treatment arm, that the study
suffers from a severe bias and that the resulting ‘‘noise’’ in
the results leads to unclear findings [15].
Conclusion
Evaluation of the SWISSspine registry showed that TDA is
efficient in short-term back and leg pain reduction. Along
with it goes an improved quality of life and moderate rates
of complications and revisions. Certain preoperative pain
threshold values correlate with postoperative outcome. The
results may provide help in every day clinical decision
making for a further optimized surgical treatment. With the
collected data, SWISSspine further accomplishes one of its
main objectives which is providing information about the
safety and efficiency of lumbar TDA. The registry can be
seen as a foundation for other data collection and evalua-
tion projects in Swiss health technology assessment. It can
also act as a feasibility model for comparable studies in
other countries.
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